Источники. 1. Balme, H.W., NSAIDs, (letter to the ed.), Lancet, 4 Feb 1984.

1. Balme, H.W., "NSAIDs", (letter to the ed.), Lancet, 4 Feb 1984.

2. Dieppe, P.A., Frankel, S.J. and Toth, В., "Is research into the treatment of osteoarthritis with non-steroidal anti-inflammatory drugs misdirected?", Lancet, Vol 341, 6 Feb 1993, pp353-4.

3. Henry, J. (ed.), The British Medical Association Guide to Medicines & Drugs, London, Dorling Kindersley, (2nd edn) 1991, pp77 and 112.

4. Markenson, J.A., "Worldwide trends in the socioeconoraic impact and long-term prognosis of rheumatoid arthritis", Seminar in Arthritis and Rheumatism, Vol 21, No 2 (Suppl. 1), Oct 1991,
pp4-12.

5. Ghosh, P. and Brooks, P., "Chondroprotection - exploring the concept", Journal of Rheumatology, Vol 18, No 2, 1991, pp161-6.

6. Bradley, J.D., Brandt, K.D., et al, "Comparison of an anti-inflammatory dose of ibuprofen, an analgesic dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthntis of the knee", New England Journal of Medicine, Vol 325, No 2, 11 Jul 1991, pp87-91.

7. Nuki, G., "Pain control and the use of non-steroidal anti-inflammatory drugs", British Medical Publication, Vol 46, No 1, 1990, pp262-78.

8. Parish, P., Medicines: a guide for everybody, London, Penguin (6th edn, revised), 1989, p197.

9. Brandt, K.D., "The mechanism of action of non-steroidal anti-inflammatory drugs", Journal of Rheumatology, (Suppl. 27) Vol 18, 1991, pp120-1.

10. Mazzuca, S.A., Brandt, K.D., et al, "The therapeutic approaches of community based primary care practitioners to osteoarthritis of the hip in an elderly patient", Journal of Rheumatology, Vol 18, No 10, 1991, pp1593-600.

11. Parish, op cit, p197.

12. Calkins, E., "Arthritis in the elderly", Bulletin on the Rheumatic Diseases, Vol 40, No 3, 1991, pp1-9.

13. WHO, The Use of Essential Drugs, Fifth report of the WHO Expert Committee (Technical Report Series No 825), Geneva, WHO, 1992, p22.

14. Mazzuca, et al, op cit.

15. Fries, J.F., Williams, C.A. and Bloch, D.A., "The relative toxicity of non-steroidal anti-inflammatory drugs", Arthritis and Rheumatism, Vol 34, No 11, Nov 1991, pp1353-60.

16. Champion, G.D., "Therapeutic usage of the non-steroidal anti-steroidal anti-inflammatory drugs", Medical Journal of Australia, Vol 149, 15 Aug 1988, pp203-13

17. Gotzsche, P.С., "Sensitivity of effect variables in rheumatoid arthritis: a metaanalysis of 130 placebo controlled NSAID trials", Journal of Clinical Epidemiology, Vol 43, No 12, 1990, pp1313-18.

18. Durnas, C. and Cusack, B.J., "Salicylate intoxication in the elderly: recognition and recommendations on how to prevent it", Drugs & Aging, Vol 2, No 1, 1992, pp20-34.

19. Brooks, P.M., "Side-effects of non-steroidal anti-inflammatory drugs", Medical Journal of Australia, Vol 148, 7 Mar 1988, pp248-51.

20. Anon., "15 years of NSAIs in Denmark", Scrip, No 1083, 10 Mar 1986, p4.

21. Fries, et al, op cit.

22. Brooks, P.M., "Clinical management of rheumatoid arthritis", Lancet, Vol 341,30 Jan 1993, pp286-90.

23. Anon., "Need for NSAI guidelines", Scrip, No 1741, 5 Aug 1992, p22.

24. Hayllar, J., Macpherson, A. and Bjarnason, I. "Gastroprotection and nonsteroidal anti-inflammatory drugs (NSAIDs): rationale and clinical implications" Drug Safety, Vol 7, No 2. 1992, pp86-105.

25. Scheiman, J.M., "Pathogenesis of gastroduodenal injury due to nonsteroidal anti-inflemmatory drugs: implications for prevention and therapy", Seminars in Arthritis and Rheumatism, Vol 21, No 4, Fab 1992, pp201-10.

26. Calkins, op cit.

27. Ibid.

28. Gay, G.R., "Another side effect of NSAIDs", Journal of the American Medical Association, Vol 264, No 20, 28 Nov 1990, pp2677-8.

29. Gilman, A.G., Rail, T.W., Nies, A.S., and Taylor, P. (eds), Goodman and Gilman's The Pharmacological Basis of Therapeutics, New York, Pergamon Press, (8th edn) 1990, p643.

30. Wijnands, M., van Riel, P., et al, "Longterm treatment with nonsteroidal anti-inflammatory drugs in rheumatoid arthritis: a prospective drug survival study", Journal of Rheumatology, Vol 18, No 2, 1991, pp184-7.

31. Anon., "Misoprostol for co-prescription with NSAIDs", Drug and Therapeutics Bulletin, Vol 28, No 7, 2 Apr 1990, pp25-6.

32. Zeidler, H., "Epidemiology of NSAID -induced gastropathy", Clinical Rheumatology, Vol 10, No 4, 1991, pp369-73.

33. Day, R., and Henry, D., "Do anti-ulcer drugs prevent gastrointestinal damage from NSAIDs?", Australian Prescriber, Vol 14, No 3, 1991, pp42-3.

34. Champion, op cit.

35. Anon., "UK arthritis costs estimated", Scrip, No 1708, 10 Apr 1992, p5.

36. Anon., "Misoprostol for co-prescription with NSAIDs", Drug and Therapeutics Bulletin, Vol 28, No 7, 2 Apr 1990, pp25-6.

37. Brooks, 1988, op cit.

38. Agrawal, N., "Risk factors for gastrointestinal ulcers caused bu nonsteroidal anti-inflammatory drugs (NSAIDs)", Journal of Family Practice, Vol 32, No 6, 1991, pp619-24.

39. Hoppmann, R.A., Peden, J.G., and Ober, S.K., "Central nervous system side effects of nonsteroidal anti-inflammatory drugs: aseptic meningitis, psychosis, and cognitive dysfunction", Archives of Internal Medicine, Vol 151, Jul 1991, pp1309-13.

40. Jones, M.P. and Schubert, M.L., "What do you recommend for prophylaxis in an elderly woman with arthritis requiring NSAIDs for control?", American Journal of Gastroenteirology, Vol 86, No 3, 1991, pp264-6.

41. Anon., The European Market for Arthritis Treatment Products, London, Frost & Sullivan, 1991.

42. Anon., The US Market for Prescription Anti-inflammatory Agents, New York, Frost & Sullivan, 1991, cited in; Anon., "US anti-inflammatory market $4 billion in 1995?", Scrip, No 1632, 10 Jul 1991, p18.

43. Anon., Scrip, No 1708, op cit, p5.

44. Anon., "Top 25 products in 1991", Scrip, No 1717, 13 May 1992, p28 (based on UBS Philips & Drew's Global Pharmaceutical Review).

45. Anon., "$270 million US sales for Ticlid?", Scrip, No 1586, 30 Jan 1991, p21.

46. Anon., Scrip, No 1717, op cit, p28.

47. Ahmad, S.R., Bitter Facts About Drugs, Karachi, HAI-Pakistan, 1990, pp233-4.

48. Dyer, С., "The penalties of issuing misleading advertisements", British Medical Journal, Vol 294, 14 Feb 1987, pp426-7.

49. Brandt, op cit; Rashad, S., Revell, P., et al, "Effect of non-steroidal anti-inflammatory drugs on the course of osteoarthntis", Lancet, No 8662, 2 Sep 1989, pp519-522.

50. Anon., "Chondroprotection", Lancet, Vol 337, 30 Mar 1991, pp769-70.

51. Anon., "Postoperative pain relief and non-opioid analgesics", Lancet, Vol 337, 2 Mar 1991, pp524-6.

52. Gay, op cit.

53. Bennett, W.M. and DeBroe, M.E., "Analgesic nephropathy - a preventable renal disease", New England Journal of Medicine, Vol 320, No 19, 11 May 1989, pp1269-71.

54. Anon., "Nonsteroidal anti-inflammatory agents: hazards of long-term use", WHO Drug Information, Vol 5, No 1, 1991, p11.

55. Anon., "NSAI restrictions on Australian PBS", Scrip, No 1790, 29 Jan 1993, p18.

56. Talley, N.J., "Chronic peptic ulceration and more to be said about NSAIDs?", Gastroenterology, Vol 102, No 3, Mar 1992, pp1074-7.

57. Bennett and DeBroe, op cit.

ЭНДРЮ ЧЕТЛИ. ПРОБЛЕМНЫЕ ЛЕКАРСТВА ЭНДРЮ ЧЕТЛИ. ПРОБЛЕМНЫЕ ЛЕКАРСТВА

Содержание:: ANTIBIOTIC.ru

Дата добавления: 2015-07-17